710
Views & Citations10
Likes & Shares
Antibodies presently available for research,
diagnostic and therapies are mostly mammalian monoclonal or polyclonal
antibodies. Traditionally, bigger animals such as horses, sheep, pigs, rabbits
and chickens were used for the production of polyclonal antibodies, Chicken
eggs present an ideal alternative antibody source to mammals, as the IgY in the
chicken’s blood is transported to the egg and accumulates in the egg yolk in
large quantities. The yolks of eggs laid by immunized chicken have been
recognized as an excellent source of polyclonal antibodies for over a decade.
This simple noninvasive approach presents an appealing alternative to
conventional polyclonal antibody production methods. This review offers
summarized information about edible IgY and the use of the antibodies for
aquaculture.
Keywords:
Antibody, Immunization, Chicken eggs, Edible IgY
INTRODUCTION
Aquaculture
is an emerging industrial sector which requires continued research with
scientific and technical developments and innovation. The aquatic environment
contains plethora of obligate and opportunistic bacterial pathogens as well as
beneficial and neutral bacterial strains. Bacterial infections are considered
to be a major cause of mortality in fish hatcheries and bacteria most
frequently associated with disease in farmed fish and shellfish are species.
Intensive
use of antimicrobial agents in aquaculture provides a selective pressure
creating reservoirs of drug-resistant bacteria and transferable resistance
genes in fish pathogens and other bacteria in the aquatic environment [1]. From
these reservoirs, resistance genes may disseminate by horizontal gene transfer
and reach human pathogens, or drug-resistant pathogens from the aquatic
environment may reach humans directly [2]. Horizontal gene transfer may occur
in the aquaculture environment. Furthermore, fish farmers must confirm that
fish are kept in the best state of health and welfare. The invention of novel
drugs or the use of alternatives to antibiotics should also be encouraged.
Vaccination
is commonly used to prevent disease outbreaks and is effective, but this kind
of method does not seem to have effect to crustaceans because crustaceans lack
a true adaptive immune response [3]. However, passive immunization using
pathogen-specific antibodies raised in hens is a potential method against
diseases, which especially make crustaceans lacking a true adaptive immune
response obtain specific antibody. Chicken eggs present an ideal alternative
antibody source to mammals, as the IgY in the chicken’s blood is transported to
the egg and accumulates in the egg yolk in large quantities. The efficiency of
egg yolk immunoglobulin (IgY) has been assessed for therapeutic application by
passive immunization therapy through oral ingestion of IgY.
IMPORTANCE OF IgY
During the
past 20 years, the use of chickens instead of mammals for antibody production
has increased. A major advantage of using birds is that the antibodies can be
harvested from the egg yolk instead of serum, thus making blood sampling
obsolete. In addition, the antibody productivity of an egg-laying hen is much
greater than that of a similar sized mammal [4]. Purification of immunoglobulin
from mammalian blood is time-consuming
IgY PRODUCTION METHODS
Immunization
Specific
IgY development and production can be achieved by immunizing laying hens with
the target antigen. However, the resulting immune response of the immunized
hens cannot be very predictable. Mainly five factors influence this response:
the antigen (dose and molecular weight), the type of adjuvant used, the route
of application, the immunization frequency, and the interval between immunizations
[6].
Antigen
The immune
response is triggered by contact of the organism with antigen, which is a
structure that is recognized by the immune system as foreign (“non-self”). The
dose of antigen influences significantly the immune response and the antibody
titre that is evoked. Too much or too little antigen may induce suppression,
sensitization, tolerance or other unwanted immunomodulation found that the
injection of antigen concentrations ranging between 10 μg and 1 mg elicited
good antibodies responses and this was also reported by other researchers [7].
Adjuvant
The
induction of high and sustainable egg yolk antibody titre reclaims the use of
adjuvant. There are more than 100 known adjuvants, which differ in their
chemical characteristics, their efficacy in stimulating the immune system, and
their secondary side-effects. In mammals, the use of Freund’s complete adjuvant
leads systematically to severe inflammation at the injection site. In birds,
the use of FCA does not seem to result in the same severe lesions as in
mammals. The results of Gassmann et al. [8] suggest that chickens show higher
resistance to tissue damaging potency of FCA than rabbits.
Route of application
The most
common route for antigen injection in hens for IgY production is the
intramuscular route. Injection is usually performed in the breast muscle.
Chicken can also be injected subcutaneously in the neck. With very young
animals, it may be preferable to inject intramuscularly into the breast muscle,
because subcutaneous injection is more difficult to perform and can therefore
cause more distress [6].
Immunization frequency
The total
number of immunizations required depends on the type and dose of the antigen as
well as the adjuvant employed. At least two immunizations have to be given.
Yolk antibody titres should be checked 14 days after the last immunization. The
success of an immunization protocol depends also on the interval between the
first and second and subsequent immunizations. Often reported interval is two
to four weeks [9].
MERITS OF IgY
IgY
technology more popular and to convince the scientific community of its
significant advantages. Chickens have the potential to be used to complete the
spectrum of animals used for Ab production. The yolks of eggs laid by immunized
chicken have been recognized as an excellent source of polyclonal antibodies
for over a decade. IgY technology is a highly innovative and expanding branch
of biotechnology which offers many advantages: it is produced by a non-invasive
method which does not cause pain to animals or lead to their death, since it is
based on the simple act of collecting eggs. Hens are inexpensive to keep than
rabbits and, furthermore, the IgY production of a hen corresponds to that of a
large mammal [6]. IgY Abs are used successfully in immunohistochemistry for
detection of antigens of viral, bacterial, plant and animal origin, and also to
assess the incidence of intestinal parasites in domestic animals and the
contamination of foods with toxins or drugs Pichler et al. [10], 1998.Since lot
of benefits of IgY technology and its universal application in both research
and medicine, it is expected that IgY will play an increasing role in research.
INFLUENCE OF IgY ON GASTROINTESTINAL TRACT
IgY can be
used long term therapeutic agent without any negative effects on animal health.
Because IgY are resistant to the gastric barrier, these are of particular
interest for passive immunotherapy of gastrointestinal tract infections. Added
to these, eggs being normal dietary element with no religious taboo issues so
pose practically no risk of toxic side effects of IgY antibodies [11]. Most
gastro intestinally absorbed proteins and peptides are believed to be
hydrolyzed at the brush border or by cytoplasmic enzymes [12]. However, various
bioactive proteins and peptides retain physiological activity when
administrated orally. Wieddemann et al. [13] postulated that IgY performed well
in the intestinal mucosa, because it could be recovered from the intestine
after oral administration which showed good resistance to enzymatic activity
and gastric acidic pH.
LIST
OF IgY DEVELOPED AGAINST MICROBIAL PATHOGENS IN AQUACULTURE
CONCLUSION
Today, there is no doubt that edible chicken
IgY can be produced and used, with minor modifications, in similar ways to the
use of mammalian Abs. It is to be
expected that studies on the therapeutic or prophylactic use of IgY Abs will be
intensified in future. In particular, because of the increasing resistance of
microorganisms to antibiotics, research on all aspects related to the
development of specific IgY against pathogenic microorganisms will have to be
intensified. IgYs can be used in aquaculture, veterinary medicine and in human
medicine. IgY technology is a fast developing field and we have tried to cover
most of its aspects in this review. We are convinced that, once accepted and
widely used, the technology will offer alternatives and solutions to science,
to medicine and to society as a whole.
1. Schmidt
AS, Bruun MS, Dalsgaard I, Pedersen K, Larsen JL (2000) Occurrence of
antimicrobial resistance in fish pathogenic and environmental bacteria
associated with four Danish rainbow trout farms. Appl Environ Microbiol 66:
4908-4915.
2. Inglis
V (1996) Antibacterial chemotherapy in aquaculture: Review of practice,
associated risks and need for action. In: Arthur JR, Lavilla-Pitogo CR and
Subasinghe RP (Eds.), Use of Chemicals in Aquaculture in Asia. Southeast Asian
Fisheries Development Centre, Aquaculture Department Tigbauan, Iloilo,
Philippines, pp: 7-22.
3. Söderhäll
K, Thornqvist PO (1997) Crustacean immunity - A short review. Fish Vaccinol 34:
45-51.
4. Hau J,
Hendriksen C (2005) Refinement of polyclonal antibody production by combining
oral immunization of chickens with harvest of antibodies from the egg yolk.
ILAR 46: 294-299.
5. Akita
EM, Nakai S (1992) Immunoglobulins from egg yolk: Isolation and purification. J Food Sci 57: 629-634.
6. Schade
R, Hlinak A (1996) Egg yolk antibodies, state of the art and future prospects. ALTEX 13: 5-9.
7. Mahn
K (1998) Etablierung eines
Immunisierungsschemas für Legehennen. PhD Thesis: University of Munich: Germany.
8. Gassmann
M, Thömmes P, Weiser T, Hübscher U (1990) Efficient production of chicken egg
yolk antibodies against a conserved mammalian protein. FASEB J 4: 2528-2532.
9. Tini M, Jewell UR, Camenisch G, Chilov D, Gassmann M (2002)
Generation and application of chicken egg-yolk antibodies. Comp Biochem Phystol
Mol Integr Phystol 131: 569-574.
10. Pichler
H, Krska R, Szekacs A, Grasserbauer M (1998) An enzyme-immunoassay for the
detection of the mycotoxin zearalenone by use of yolk antibodies. Fresenius J Anal Chem 362: 176-177.
11. Zorriehzahra MJ, Tiwari R, Sachan S, Karthik
K, Malik Y, et al. (2016) Avian egg
yolk antibodies (IgY) and their potential therapeutic applications for
countering infectious diseases of fish and aquatic animals. Int J Pharmacol 12: 760-768.
12. Sire MF, Vernier LM (1992) Intestinal
absorption of protein in teleost fish. Comp Biochem Physiol 103: 771-781.
13. Wieddemann V, Kuè Hlmann R, Schimidt P, Erhardt
W, Loè Sch U (1990) Chicken egg antibody for prophylaxis and therapy of
infectious intestinal diseases. J Vet Med 37: 163-172.
14. Ebina
T (1996) Prophylaxis of rotavirus gastroenteritis using immunoglobulin. Arch Virol 12: 217-223.
15. Akhlaghi
M (1999) Passive immunization of fish against vibriosis, comparison of
intraperitoneal, oral and immersion routes.; Aquaculture 180: 191-205.
16. Lee SB, Mine Y, Stevenson KMW (2000)
Effects of hen egg yolk
immunoglobulin passive protection of rainbow trout against Yersinia ruckeri. J Agric
Food Chem 48: 110-115.
17. Carlander
D, Larsson A (2001) Avian antibodies can eliminate interference due to
complement activation in ELISA. Uppsala J Med Sci 106: 189-195.
18. Mine
Y, Kovacs-Nolan J (2002) Chicken egg yolk antibodies as therapeutics in enteric
infectious disease. J Med Food 5: 159-169.
19. Lee KA, Chang SK, Lee YJ, Lee JH, Koo
NS (2002) Acid stability of anti-Helicobacter pyroli IgY in aqueous
polyol solution. J Biochem Mol Biol 35: 488-493.
20. Shin
JH, Nam SW, Kim JT, Yoon JB, Bang WG (2003) Identification of immunodominant Helicobacter pylori proteins with
reactivity to H. pylori-specific
egg-yolk immunoglobulin. J Med Microbiol 52: 217-222.
21. Kim DK, Jang IK, Seo HC, Shin SO, Yang SY, et
al. (2004) Shrimp protected from WSSV disease by treatment with egg yolk
antibodies (IgY) against a truncated fusion protein derived from WSSV. Aquaculture
237: 21-30.
22. Kumaran
T, Babu MM, Selvaraj T, Albindhas S,
Citarasu T, et al. (2010) Immunoadjuvant efficiency of Asparagus
racemosus extract against WSSV infection in shrimp aquaculture. J Aquacult
Feed Sci Nutr 2: 1-5.
23. Meenatchisundaram
S, Michael A, Subbraj T, Diraviam T, Shanmugam V (2011) Isolation, purification
and neutralizing potential of chicken egg yolk immunoglobulin (IgY) against
mastitis causing Escherichia coli in
dairy cows in Coimbatore district. Int J Drug Dev Res 3: 147-153.
24. Barati H, Moradi G, Rasouli MA, Mohammadi P
(2015) Epidemiologic and drug resistance pattern of Vibrio cholerae O1 Biotype El Tor, serotype Ogawa, in the 2011 cholera
outbreak in Alborz Province, Iran. Jundishapur J Microbiol 8: e23477.
25. Kumaran
T, Thirumalaikumar E, Lelin C, Palanikumar P, Michaelbabu M, et al. (2018) Physicochemical properties of anti-Vibrio harveyi egg yolk antibody (IgY)
and its immunological influence in Indian white shrimp Fenneropenaeus indicus. Fish Shellfish Immunol 74: 349-362.